Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01186835 · ClinicalTrials.gov registry record · NA
Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01186835 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 20 participants.
The verdict
NCT01186835, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether the use of botulinum toxin (Dysport ®) in conjunction with a hyaluronic acid filler (Restylane®) will improve the appearance of wrinkles on the forehead and glabella (area between the eyebrows) better than botulinum toxin alone. These two products have been FDA approved to improve the appearance of facial wrinkles.
Interventions
- PROCEDURE Botulinum Toxin A
- PROCEDURE Combination Botulinum Toxin A and Hyaluronic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01186835
The ClinicalTrials.gov registry entry for NCT01186835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botulinum Toxin A is the first listed.
NCT01186835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01186835 about?
NCT01186835 is a clinical study titled "Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone". The objective of this study is to determine whether the use of botulinum toxin (Dysport ®) in conjunction with a hyaluronic acid filler (Restylane®) will improve the appearance of wrinkles on the forehead and glabella (area between the eyebrows) better than botulinum toxin alone. These two products ...
What is the current status of trial NCT01186835?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-02. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01186835?
The interventions under investigation include: Botulinum Toxin A (PROCEDURE), Combination Botulinum Toxin A and Hyaluronic Acid (PROCEDURE).
Who is sponsoring clinical trial NCT01186835?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.